These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 26622057)
1. Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI. Schulz A; Viktil E; Godt JC; Johansen CK; Dormagen JB; Holtedahl JE; Labori KJ; Bach-Gansmo T; Kløw NE Acta Radiol; 2016 Sep; 57(9):1040-8. PubMed ID: 26622057 [TBL] [Abstract][Full Text] [Related]
2. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI. Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation. Sivesgaard K; Larsen LP; Sørensen M; Kramer S; Schlander S; Amanavicius N; Bharadwaz A; Tønner Nielsen D; Viborg Mortensen F; Morre Pedersen E Eur Radiol; 2018 Nov; 28(11):4735-4747. PubMed ID: 29736846 [TBL] [Abstract][Full Text] [Related]
4. Feasibility of Routine Application of Gadoxetic Acid-Enhanced MRI in Combination with Diffusion-Weighted MRI for the Preoperative Evaluation of Colorectal Liver Metastases. Tanaka M; Kishi Y; Esaki M; Nara S; Miyake M; Hiraoka N; Nagino M; Shimada K Ann Surg Oncol; 2016 Nov; 23(12):3991-3998. PubMed ID: 27357179 [TBL] [Abstract][Full Text] [Related]
5. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases. Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131 [TBL] [Abstract][Full Text] [Related]
6. Respiratory gated PET/CT of the liver: A novel method and its impact on the detection of colorectal liver metastases. Schulz A; Godt JC; Dormagen JB; Holtedahl JE; Bogsrud TV; Labori KJ; Kløw NE; Bach-Gansmo T Eur J Radiol; 2015 Aug; 84(8):1424-1431. PubMed ID: 26044293 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of CT, gadoxetate disodium-enhanced MRI, and PET/CT for the diagnosis of colorectal liver metastasis: Systematic review and meta-analysis. Choi SH; Kim SY; Park SH; Kim KW; Lee JY; Lee SS; Lee MG J Magn Reson Imaging; 2018 May; 47(5):1237-1250. PubMed ID: 28901685 [TBL] [Abstract][Full Text] [Related]
8. Prospective comparison of gadoxetic acid-enhanced liver MRI and contrast-enhanced CT with histopathological correlation for preoperative detection of colorectal liver metastases following chemotherapy and potential impact on surgical plan. Jhaveri KS; Fischer SE; Hosseini-Nik H; Sreeharsha B; Menezes RJ; Gallinger S; Moulton CE HPB (Oxford); 2017 Nov; 19(11):992-1000. PubMed ID: 28760631 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Niekel MC; Bipat S; Stoker J Radiology; 2010 Dec; 257(3):674-84. PubMed ID: 20829538 [TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy. Hosseini-Nik H; Fischer SE; Moulton CA; Karbhase G; Menezes RJ; Gallinger S; Jhaveri KS Abdom Radiol (NY); 2016 Feb; 41(2):231-8. PubMed ID: 26867904 [TBL] [Abstract][Full Text] [Related]
11. Detection and Viability of Colorectal Liver Metastases After Neoadjuvant Chemotherapy: A Multiparametric PET/CT-MRI Study. Dunet V; Halkic N; Prior JO; Anaye A; Meuli RA; Sempoux C; Denys A; Schmidt S Clin Nucl Med; 2017 Apr; 42(4):258-263. PubMed ID: 28166142 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms. Armbruster M; Zech CJ; Sourbron S; Ceelen F; Auernhammer CJ; Rist C; Haug A; Singnurkar A; Reiser MF; Sommer WH J Magn Reson Imaging; 2014 Aug; 40(2):457-66. PubMed ID: 24347148 [TBL] [Abstract][Full Text] [Related]
13. Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents. Mainenti PP; Mancini M; Mainolfi C; Camera L; Maurea S; Manchia A; Tanga M; Persico F; Addeo P; D'Antonio D; Speranza A; Bucci L; Persico G; Pace L; Salvatore M Abdom Imaging; 2010 Oct; 35(5):511-21. PubMed ID: 19562412 [TBL] [Abstract][Full Text] [Related]
14. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI. Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103 [TBL] [Abstract][Full Text] [Related]
15. Detection of liver metastasis: is diffusion-weighted imaging needed in Gd-EOB-DTPA-enhanced MR imaging for evaluation of colorectal liver metastases? Tajima T; Akahane M; Takao H; Akai H; Kiryu S; Imamura H; Watanabe Y; Kokudo N; Ohtomo K Jpn J Radiol; 2012 Oct; 30(8):648-58. PubMed ID: 22836904 [TBL] [Abstract][Full Text] [Related]
16. Is 3-Tesla Gd-EOB-DTPA-enhanced MRI with diffusion-weighted imaging superior to 64-slice contrast-enhanced CT for the diagnosis of hepatocellular carcinoma? Maiwald B; Lobsien D; Kahn T; Stumpp P PLoS One; 2014; 9(11):e111935. PubMed ID: 25375778 [TBL] [Abstract][Full Text] [Related]
17. Clinical added value of MRI to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): study protocol for an international multicentre prospective diagnostic accuracy study. Görgec B; Hansen I; Kemmerich G; Syversveen T; Abu Hilal M; Belt EJT; Bisschops RHC; Bollen TL; Bosscha K; Burgmans MC; Cappendijk V; De Boer MT; D'Hondt M; Edwin B; Gielkens H; Grünhagen DJ; Gillardin P; Gobardhan PD; Hartgrink HH; Horsthuis K; Kok NFM; Kint PAM; Kruimer JWH; Leclercq WKG; Lips DJ; Lutin B; Maas M; Marsman HA; Morone M; Pennings JP; Peringa J; Te Riele WW; Vermaas M; Wicherts D; Willemssen FEJA; Zonderhuis BM; Bossuyt PMM; Swijnenburg RJ; Fretland ÅA; Verhoef C; Besselink MG; Stoker J; BMC Cancer; 2021 Oct; 21(1):1116. PubMed ID: 34663243 [TBL] [Abstract][Full Text] [Related]
18. Routine Preoperative Liver-specific Magnetic Resonance Imaging Does Not Exclude the Necessity of Contrast-enhanced Intraoperative Ultrasound in Hepatic Resection for Colorectal Liver Metastasis. Arita J; Ono Y; Takahashi M; Inoue Y; Takahashi Y; Matsueda K; Saiura A Ann Surg; 2015 Dec; 262(6):1086-91. PubMed ID: 26010441 [TBL] [Abstract][Full Text] [Related]
19. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330 [TBL] [Abstract][Full Text] [Related]
20. Imaging of colorectal cancer liver metastases using contrast-enhanced US, multidetector CT, MRI, and FDG PET/CT: a meta-analysis. Tsili AC; Alexiou G; Naka C; Argyropoulou MI Acta Radiol; 2021 Mar; 62(3):302-312. PubMed ID: 32506935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]